Anbio Biotechnology (NNNN) · Peers
Anbio Biotechnology against the 15 other companies here in its SEC industry, In Vitro & In Vivo Diagnostic Substances. Each figure is the one on the company's own page; the median is the peers', and the rank is among all 16, highest first.
Measure by measure
| Measure | NNNN | Peer median | Rank |
|---|---|---|---|
| Market value | $140.54M | median $380.11M | 9 of 16 |
| P/E | 21.9× | median 25.9× | 4 of 4 |
| EV/EBITDA | 22.3× | median 22.1× | 3 of 5 |
| P/S | 16.3× | median 4.2× | 5 of 16 |
| FCF yield | -4.8% | median -16.1% | 7 of 15 |
| Gross margin | 87.2% | median 48.3% | 1 of 12 |
| Operating margin | 66.7% | median -30.8% | 1 of 12 |
| Net margin | 74.1% | median -38.4% | 1 of 12 |
| ROIC | 25.0% | median -17.6% | 2 of 11 |
| ROE | 21.2% | median -37.1% | 2 of 12 |
| Current ratio | 344.3× | median 2.9× | 1 of 15 |
| Stock pay / revenue | 0.0% | median 5.3% | 15 of 15 |
| Share count change | 3.3% | median 9.4% | 9 of 15 |
Green where Anbio Biotechnology is on the better side of the median, red where on the worse; no colour where higher is neither, like size or dividend yield.
The peers, largest first
| Company | Market value | P/E | ROIC | Score |
|---|---|---|---|---|
| NNNNAnbio Biotechnology | $140.54M | P/E 21.9× | 25.0% | 6.7 |
| IDXXIDEXX Laboratories Inc | $44.15B | P/E 38.7× | 57.2% | 6.8 |
| LNTHLantheus Holdings, Inc. | $6.53B | P/E 23.7× | 18.5% | 7.7 |
| NEOGNeogen Corp | $2.59B | P/E – | -0.6% | 4.4 |
| CLDXCelldex Therapeutics, Inc. | $2.24B | P/E – | – | 2.7 |
| NTLAIntellia Therapeutics, Inc. | $1.63B | P/E – | -115.4% | 3.8 |
| QDELQuidelOrtho Corp | $913.77M | P/E – | -13.8% | 3.0 |
| MYGNMyriad Genetics Inc | $389.29M | P/E – | -25.2% | 5.3 |
| TKNOAlpha Teknova, Inc. | $380.11M | P/E – | -21.4% | 4.3 |
| IMDXInsight Molecular Diagnostics Inc. | $98.50M | P/E – | – | 3.4 |
| ICCCImmucell Corp | $97.63M | P/E 25.9× | 9.8% | 7.2 |
| AWHLAspira Women's Health Inc. | $10.73M | P/E – | – | 4.5 |
| BMRABiomerica Inc | $8.49M | P/E – | -213.5% | 3.0 |
| CDIOCardio Diagnostics Holdings, Inc. | $5.00M | P/E – | -68.7% | 3.7 |
| QCLSQ/C Technologies, Inc. | $4.22M | P/E – | – | 8.0 |
| VNRXVolitionrx Ltd | $2.46M | P/E – | – | 4.1 |
The industry is the Standard Industrial Classification code the company registered with the SEC. It is a broad label: a peer group is a starting point for comparing, not proof that two businesses are alike. None of this is advice.